FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

20472311000001105: Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1320691000001111 Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1320701000001111 Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1940961000001118 Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1940971000001111 Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68985901000001116 Caelyx 50mg/25ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
68986001000001113 Caelyx 50mg/25ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Is a Doxorubicin liposomal pegylated 50mg/25ml solution for infusion vials true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has specific active ingredient Doxorubicin hydrochloride liposomal pegylated true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has active ingredient Doxorubicin true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Is a Caelyx true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Has basis of strength substance Doxorubicin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) 1 vial Has AMP True Caelyx pegylated liposomal 50mg/25ml concentrate for solution for infusion vials (Baxter Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start